Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients in Premenopausal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001837
What this trial is testing

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

Who this might be right for
Breast CancerBreast Neoplasm
National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Study completedNCT05896566
What this trial is testing

A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 231
Not applicableLooking for participantsNCT05910294
What this trial is testing

Prevent and Improve Sexual Health Concerns for People With Breast Cancer

Who this might be right for
Improve Sexual HealthImprove Vulvovaginal Health
Memorial Sloan Kettering Cancer Center 50
Not applicableEnded earlyNCT01726322
What this trial is testing

Ovarian Reserve in Premenopausal Breast Cancer

Who this might be right for
Premenopausal Breast CancerBreast Cancer
Cancer Trials Ireland 216
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Large-scale testing (Phase 3)Ended earlyNCT03936933
What this trial is testing

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

Who this might be right for
Breast Cancer
Eurofarma Laboratorios S.A. 6
Early research (Phase 1)Study completedNCT02152943
What this trial is testing

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more
M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)Study completedNCT00311636
What this trial is testing

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 280
Large-scale testing (Phase 3)Ended earlyNCT02532400
What this trial is testing

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Ruijin Hospital 21
Large-scale testing (Phase 3)Study completedNCT00002784
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 344
Large-scale testing (Phase 3)Study completedNCT00427245
What this trial is testing

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast CancerInfertilityMenopausal Symptoms
Anglo Celtic Cooperative Oncology Group 400
Testing effectiveness (Phase 2)Ended earlyNCT00555477
What this trial is testing

Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 69
Not applicableActive Not RecruitingNCT05612100
What this trial is testing

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

Who this might be right for
Breast Carcinoma
Mayo Clinic 169
Post-approval studies (Phase 4)Study completedNCT00999921
What this trial is testing

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Who this might be right for
Benign Breast DiseaseFibrocystic Disease of BreastFibroadenoma+1 more
Medical College and Hospital Kolkata 256
Not applicableActive Not RecruitingNCT05730647
What this trial is testing

Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients

Who this might be right for
Early Breast Cancer
Consorzio Oncotech 600
Testing effectiveness (Phase 2)Study completedNCT03839823
What this trial is testing

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 222
Large-scale testing (Phase 3)UnknownNCT00412022
What this trial is testing

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

Who this might be right for
Breast Cancer
National Cancer Institute, Naples 1,294
Testing effectiveness (Phase 2)Looking for participantsNCT05982093
What this trial is testing

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHormone Receptor Positive Tumor+1 more
SOLTI Breast Cancer Research Group 96
Not applicableNot Yet RecruitingNCT07833501
What this trial is testing

Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast Cancer
D'Or Institute for Research and Education 172
Testing effectiveness (Phase 2)Looking for participantsNCT07159451
What this trial is testing

A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 140
Next Page